Najjam Asghar is the Sr. VP & CFO at Sorrento Therapeutics Inc.
As the Sr. VP & CFO of Sorrento Therapeutics Inc, the total compensation of Mr Asghar at Sorrento Therapeutics Inc is $511,692. There are 3 executives at Sorrento Therapeutics Inc getting paid more, with Jaisim Shah having the highest compensation of $10,971,100.
Mr Asghar is 40, he's been the Sr. VP & CFO of Sorrento Therapeutics Inc since . There are 11 older and 1 younger executives at Sorrento Therapeutics Inc. The oldest executive at Sorrento Therapeutics Inc is Dr. Michael A. Royal, 67, who is the SVP & Chief Medical Officer.
Najjam's mailing address filed with the SEC is C/O SORRENTO THERAPEUTICS, INC., 4955 DIRECTORS PLACE, SAN DIEGO, CA, 92121.
Over the last 15 years, insiders at Sorrento Therapeutics Inc have traded over $17,198,839 worth of Sorrento Therapeutics Inc stock and bought 10,353,437 units worth $10,703,222 . The most active insiders traders include Jane Ph D Hsiao, Edgar Lee és Patrick Chan Soon Shiong Fa.... On average, Sorrento Therapeutics Inc executives and independent directors trade stock every 60 days with the average trade being worth of $2,947. The most recent stock trade was executed by Henry Ji on 7 September 2022, trading 88,888 units of SRNE stock currently worth $179,554.
sorrento therapeutics is an antibody-centric, clinical stage biopharmaceutical company developing new treatments for cancer, inflammation and autoimmune diseases. sorrento's lead products are multiple late-stage biosimilar and biobetter antibodies, as well as clinical car-t therapies targeting solid tumors.
Sorrento Therapeutics Inc executives and other stock owners filed with the SEC include: